These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 28757603)

  • 21. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of FOXP3 in regulating immune responses.
    Vent-Schmidt J; Han JM; MacDonald KG; Levings MK
    Int Rev Immunol; 2014 Mar; 33(2):110-28. PubMed ID: 23947341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foxp3 Post-translational Modifications and Treg Suppressive Activity.
    Deng G; Song X; Fujimoto S; Piccirillo CA; Nagai Y; Greene MI
    Front Immunol; 2019; 10():2486. PubMed ID: 31681337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phenotypic Screening Approach Using Human Treg Cells Identified Regulators of Forkhead Box p3 Expression.
    Ding M; Brengdahl J; Lindqvist M; Gehrmann U; Ericson E; von Berg S; Ripa L; Malhotra R
    ACS Chem Biol; 2019 Mar; 14(3):543-553. PubMed ID: 30807094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
    Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
    Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.
    Dong Y; Yang C; Pan F
    Front Immunol; 2021; 12():626172. PubMed ID: 33912156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus.
    La Rocca C; Carbone F; Longobardi S; Matarese G
    Immunol Lett; 2014 Nov; 162(1 Pt A):41-8. PubMed ID: 24996040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells.
    Morikawa H; Sakaguchi S
    Immunol Rev; 2014 May; 259(1):192-205. PubMed ID: 24712467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function.
    Wang A; Yang M; Liang R; Zhu F; Zhu F; Liu X; Han Y; Lin R; Wang X; Li D; Li H; Yuan X; Zhao H; Li B
    Front Immunol; 2020; 11():1087. PubMed ID: 32636834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
    Campbell DJ; Ziegler SF
    Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trafficking of FoxP3+ regulatory T cells: myths and facts.
    Kim CH
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of FOXP3 in autoimmunity.
    Pesenacker AM; Cook L; Levings MK
    Curr Opin Immunol; 2016 Dec; 43():16-23. PubMed ID: 27544816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FoxP3 in T
    Deng G; Song X; Greene MI
    Clin Exp Immunol; 2020 Mar; 199(3):255-262. PubMed ID: 31386175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
    Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
    Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells.
    Fan MY; Turka LA
    Front Immunol; 2018; 9():69. PubMed ID: 29434595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXP3 and RORγt: transcriptional regulation of Treg and Th17.
    Chen Z; Lin F; Gao Y; Li Z; Zhang J; Xing Y; Deng Z; Yao Z; Tsun A; Li B
    Int Immunopharmacol; 2011 May; 11(5):536-42. PubMed ID: 21081189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.